Betamethasone for Trigger Finger

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Trigger FingerMethylprednisolone - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether one of two common corticosteroids is better at treating trigger finger, with the goal of reducing pain.

Eligible Conditions
  • Trigger Finger

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
PR006
1
PR001
1
elotuzumab

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: Up to 7 days

Day 7
Peak of flare reaction
Up to 7 days
Incidence of pain
Intensity of pain
Resolution of flare reaction

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
PR006
1
PR001
2
elotuzumab

Trial Design

2 Treatment Groups

Betamethasone
1 of 2
Methylprednisolone
1 of 2

Active Control

100 Total Participants · 2 Treatment Groups

Primary Treatment: Betamethasone · No Placebo Group · Phase 4

Betamethasone
Drug
ActiveComparator Group · 1 Intervention: Betamethasone · Intervention Types: Drug
Methylprednisolone
Drug
ActiveComparator Group · 1 Intervention: Methylprednisolone · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 7 days

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
161 Previous Clinical Trials
50,337 Total Patients Enrolled
Shatic Sraj, MDPrincipal InvestigatorWest Virginia University

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The digit was used for the first time.
You have no prior surgery on the digit.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top